Loading AI feed…

AI Stock Memo: GLRE - Greenlight Capital Re - RankAlpha

GLRE

Rating neutralAI MemoPost-earnings T+3

Greenlight Capital Re

As of 2026-05-08/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-08 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q1 earnings confirmed improved underwriting and book value growth • 2026-05-05

Base target: $19 / p=50% prob

Biggest risk

The cautious read is that gross premiums written still fell 8%, Innovations posted a 102.3% combined ratio, and the earnings model remains meaningfully exposed to Solasglas investment performance and catastrophe/reserve volatility; delayed analyst revision data was not available in the packet and was not confirmed from primary follow-up sources.

Invalidation

Break below $16 or thesis failure.

What would change my mind?

The strongest post-earnings bull read is that GLRE converted a prior-year underwriting loss into a $6.2 million underwriting profit, improved the combined ratio by 8.6 points, and increased fully diluted book value per share to $21.40 while buying back stock below that level [#8-K-2026-05-05].

Research note

Recommendation

neutral

Confidence

medium

As of

2026-05-08

Base target

$19

p=50%

Bull target

$21

p=25%

Bear target

$16

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Share repurchases can remain an accretive near-term support if the discount to book persists
Sustained underwriting profitability plus Solasglas returns are the main path to further re-rating
The strongest post-earnings bull read is that GLRE converted a prior-year underwriting loss into a $6.2 million underwriting profit, improved the combined ratio by 8.6 points, and increased fully diluted book value per share to $21.40 while buying back stock below that level [#8-K-2026-05-05].

BearKey bullets

Gross premiums written declined 8% year over year in Q1 2026, limiting evidence of broad-based top-line acceleration [#8-K-2026-05-05].
Investment results remain central to earnings and book-value progression, leaving the thesis sensitive to Solasglas performance and market volatility [#8-K-2026-05-05] [#10-K-2026-03-09].
Primary-source risk factors still include catastrophe losses, significant broker concentration, ratings pressure, and valuation uncertainty in innovation investments [#10-K-2026-03-09].

WatchKey bullets

Q1 earnings confirmed improved underwriting and book value growth

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $19 (p=50%)

Target spread vs base: +11% / -16%

Scenario probabilities

Bull Target: $21 (p=25%)Base Target: $19 (p=50%)Bear Target: $16 (p=25%)

Commentary

This is a cautious T+3 post-earnings update. The company source clearly confirmed better underwriting, book-value growth, and ongoing buybacks, but the stock’s May 7 anchor price of $17.80 still sat below reported fully diluted book value per share of $21.40, suggesting only a muted rerating so far [#8-K-2026-05-05]. Low external coverage remains a material limitation: the packet showed no usable analyst-target set and no confirmed delayed revision wave, so missing analyst reaction should be treated as an evidence gap rather than positive confirmation.

As of 2026-05-08 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Share repurchases can remain an accretive near-term support if the discount to book persists
Sustained underwriting profitability plus Solasglas returns are the main path to further re-rating

Scenarios

Bull Target (Scenario probability)

$21 / p=25% prob

Base Target (Scenario probability)

$19 / p=50% prob

Bear Target (Scenario probability)

$16 / p=25% prob

Analysis 2026-05-08 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-05
Q1 earnings confirmed improved underwriting and book value growth
The May 5, 2026 earnings release showed net underwriting income of $6.2 million versus a loss a year ago, a combined ratio improvement to 96.0% from 104.6%, net income of $35.8 million, and fully diluted book value per share up 4.7% from year-end to $21.40, giving investors a cleaner post-earnings read on underwriting discipline and capital generation [#8-K-2026-05-05].
Prob 95.00% • Move 4.00% • Priced-in 75.00%

Short-term Catalysts

Next few weeks

Share repurchases can remain an accretive near-term support if the discount to book persists
2026-06-30
Management disclosed $5.0 million of buybacks in Q1 at $16.70 per share and another $9.5 million in April at $18.38, while fully diluted book value per share was reported at $21.40; continued repurchases at a discount would be incrementally supportive, but the scale is still modest for thesis change [#8-K-2026-05-05].
Prob 65% • Move 6% • Priced-in 45%

Long-term Catalysts

Months to a year

Sustained underwriting profitability plus Solasglas returns are the main path to further re-rating
2026-12-31
The operating model still depends on both underwriting execution and investment results: Q1 open-market underwriting improved materially, Innovations gross premiums written rose to $47.6 million from $27.5 million, and Solasglas contributed $33.7 million of income, but this mix also means future book-value growth remains sensitive to market and reserve outcomes [#8-K-2026-05-05] [#10-K-2026-03-09].
Prob 45% • Move 12% • Priced-in 40%

Risks

Gross premiums written declined 8% year over year in Q1 2026, limiting evidence of broad-based top-line acceleration [#8-K-2026-05-05].
Investment results remain central to earnings and book-value progression, leaving the thesis sensitive to Solasglas performance and market volatility [#8-K-2026-05-05] [#10-K-2026-03-09].
Primary-source risk factors still include catastrophe losses, significant broker concentration, ratings pressure, and valuation uncertainty in innovation investments [#10-K-2026-03-09].
The Innovations segment reported a 102.3% combined ratio in Q1 2026, so not all growth areas are yet showing consistent underwriting profitability [#8-K-2026-05-05].

Peers

Symbol	Summary
AMSF	Same-sector small-cap insurance peer from the packet’s market-cap cohort; useful benchmark for how consistently profitable underwriting franchises are valued versus GLRE’s more investment-linked profile.
DGICA	Same-sector insurance peer in a similar market-cap range from the packet; useful reference for reserve, combined-ratio, and book-value multiple comparisons among smaller insurers.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-05-08